{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:02:36Z","timestamp":1791378156300,"version":"4.3.2"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Roma La Sapienza"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hereditary spastic paraparesis (HSP) is a group of central nervous system diseases primarily affecting the spinal upper motor neurons, with different inheritance patterns and phenotypes. SPG46 is a rare, early-onset and autosomal recessive HSP, linked to biallelic <jats:italic>GBA2<\/jats:italic> mutations. About thirty families have been described worldwide, with different phenotypes like complicated HSP, recessive cerebellar ataxia or Marinesco-Sj\u00f6gren Syndrome. Herein, we report five SPG46 patients harbouring five novel <jats:italic>GBA2<\/jats:italic> mutations, the largest series described in Italy so far. Probands were enrolled in five different centres and underwent neurological examination, clinical cognitive assessment, column imaging for scoliosis assessment, ophthalmologic examination, brain imaging, GBA2 activity in peripheral blood cells and genetic testing. Their phenotype was consistent with HSP, with notable features like upper gaze palsy and movement disorders. We review demographic, genetic, biochemical and clinical information from all documented cases in the existing literature, focusing on the global distribution of cases, the features of the syndrome, its variable presentation, new potential identifying features and the significance of measuring GBA2 enzyme activity.<\/jats:p>","DOI":"10.1007\/s10048-024-00749-9","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T07:02:35Z","timestamp":1707462155000},"page":"51-67","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hereditary spastic paraparesis type 46 (SPG46): new GBA2 variants in a large Italian case series and review of the literature"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9720-1065","authenticated-orcid":false,"given":"Ettore","family":"Cioffi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olimpia","family":"Musumeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Gallone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorella","family":"Piemonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Tessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo Maria","family":"Santorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Casali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,9]]},"reference":[{"key":"749_CR1","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/S1474-4422(08)70258-8","volume":"7","author":"S Salinas","year":"2008","unstructured":"Salinas S, Proukakis C, Crosby A, Warner TT (2008) Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms. Lancet Neurol 7:1127\u20131138. https:\/\/doi.org\/10.1016\/S1474-4422(08)70258-8","journal-title":"Lancet Neurol"},{"key":"749_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1136\/jnnp.37.1.8","volume":"37","author":"WMH Behan","year":"1974","unstructured":"Behan WMH, Maia M (1974) Strumpell\u2019s familial spastic paraplegia: genetics and neuropathology. J Neurol Neurosurg Psychiatry 37:8\u201320. https:\/\/doi.org\/10.1136\/jnnp.37.1.8","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"749_CR3","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/j.1365-2990.2004.00587.x","volume":"30","author":"GC DeLuca","year":"2004","unstructured":"DeLuca GC, Ebers GC, Esiri MM (2004) The extent of axonal loss in the long tracts in hereditary spastic paraplegia: axonal loss in hereditary spastic paraplegia. Neuropathol Appl Neurobiol 30:576\u2013584. https:\/\/doi.org\/10.1111\/j.1365-2990.2004.00587.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"749_CR4","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.neurol.2017.03.034","volume":"173","author":"L Parodi","year":"2017","unstructured":"Parodi L, Fenu S, Stevanin G, Durr A (2017) Hereditary spastic paraplegia: more than an upper motor neuron disease. Rev Neurol 173:352\u2013360. https:\/\/doi.org\/10.1016\/j.neurol.2017.03.034","journal-title":"Rev Neurol"},{"key":"749_CR5","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.neurol.2020.07.001","volume":"177","author":"P Lallemant-Dudek","year":"2021","unstructured":"Lallemant-Dudek P, Durr A (2021) Clinical and genetic update of hereditary spastic paraparesis. Rev Neurol 177:550\u2013556. https:\/\/doi.org\/10.1016\/j.neurol.2020.07.001","journal-title":"Rev Neurol"},{"key":"749_CR6","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000358801","volume":"42","author":"L Ruano","year":"2014","unstructured":"Ruano L, Melo C, Silva MC, Coutinho P (2014) The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology 42:174\u2013183. https:\/\/doi.org\/10.1159\/000358801","journal-title":"Neuroepidemiology"},{"key":"749_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2012.03.025","volume":"318","author":"J Finsterer","year":"2012","unstructured":"Finsterer J, L\u00f6scher W, Quasthoff S et al (2012) Hereditary spastic paraplegias with autosomal dominant, recessive, X-linked, or maternal trait of inheritance. J Neurol Sci 318:1\u201318. https:\/\/doi.org\/10.1016\/j.jns.2012.03.025","journal-title":"J Neurol Sci"},{"key":"749_CR8","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s12311-016-0803-z","volume":"16","author":"PVS de Souza","year":"2017","unstructured":"de Souza PVS, de Rezende Pinto WBV, de RezendeBatistella GN et al (2017) Hereditary spastic paraplegia: clinical and genetic hallmarks. Cerebellum 16:525\u2013551. https:\/\/doi.org\/10.1007\/s12311-016-0803-z","journal-title":"Cerebellum"},{"key":"749_CR9","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.expneurol.2014.06.011","volume":"261","author":"T Lo Giudice","year":"2014","unstructured":"Lo Giudice T, Lombardi F, Santorelli FM et al (2014) Hereditary spastic paraplegia: clinical-genetic characteristics and evolving molecular mechanisms. Exp Neurol 261:518\u2013539. https:\/\/doi.org\/10.1016\/j.expneurol.2014.06.011","journal-title":"Exp Neurol"},{"key":"749_CR10","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1136\/jnnp.44.10.871","volume":"44","author":"AE Harding","year":"1981","unstructured":"Harding AE (1981) Hereditary \u201cpure\u201d spastic paraplegia: a clinical and genetic study of 22 families. J Neurol Neurosurg Psychiatry 44:871\u2013883. https:\/\/doi.org\/10.1136\/jnnp.44.10.871","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"749_CR11","unstructured":"Hedera P. Hereditary Spastic Paraplegia Overview. 2000 Aug 15 [Updated 2021 Feb 11]. In: Adam MP, Feldman J, Mirzaa GM et al (eds) GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1509\/"},{"key":"749_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1148\/radiol.14141715","volume":"276","author":"F Agosta","year":"2015","unstructured":"Agosta F, Scarlato M, Spinelli EG et al (2015) Hereditary spastic paraplegia: beyond clinical phenotypes toward a unified pattern of central nervous system damage. Radiology 276:207\u2013218. https:\/\/doi.org\/10.1148\/radiol.14141715","journal-title":"Radiology"},{"key":"749_CR13","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3174\/ajnr.A1483","volume":"30","author":"R Hourani","year":"2009","unstructured":"Hourani R, El-Hajj T, Barada WH et al (2009) MR imaging findings in autosomal recessive hereditary spastic paraplegia. AJNR Am J Neuroradiol 30:936\u2013940. https:\/\/doi.org\/10.3174\/ajnr.A1483","journal-title":"AJNR Am J Neuroradiol"},{"key":"749_CR14","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3389\/fneur.2018.01117","volume":"9","author":"FF da Gra\u00e7a","year":"2018","unstructured":"da Gra\u00e7a FF, de Rezende TJR, Vasconcellos LFR et al (2018) Neuroimaging in hereditary spastic paraplegias: current use and future perspectives. Front Neurol 9:1117. https:\/\/doi.org\/10.3389\/fneur.2018.01117","journal-title":"Front Neurol"},{"key":"749_CR15","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.neurol.2015.02.017","volume":"171","author":"S Klebe","year":"2015","unstructured":"Klebe S, Stevanin G, Depienne C (2015) Clinical and genetic heterogeneity in hereditary spastic paraplegias: from SPG1 to SPG72 and still counting. Rev Neurol 171:505\u2013530. https:\/\/doi.org\/10.1016\/j.neurol.2015.02.017","journal-title":"Rev Neurol"},{"key":"749_CR16","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10048-010-0249-2","volume":"11","author":"A Boukhris","year":"2010","unstructured":"Boukhris A, Feki I, Elleuch N et al (2010) A new locus (SPG46) maps to 9p21.2-q21.12 in a Tunisian family with a complicated autosomal recessive hereditary spastic paraplegia with mental impairment and thin corpus callosum. Neurogenetics 11:441\u2013448. https:\/\/doi.org\/10.1007\/s10048-010-0249-2","journal-title":"Neurogenetics"},{"key":"749_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00415-013-7206-6","volume":"261","author":"A Citterio","year":"2014","unstructured":"Citterio A, Arnoldi A, Panzeri E et al (2014) Mutations in CYP2U1, DDHD2 and GBA2 genes are rare causes of complicated forms of hereditary spastic paraparesis. J Neurol 261:373\u2013381. https:\/\/doi.org\/10.1007\/s00415-013-7206-6","journal-title":"J Neurol"},{"key":"749_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/ahg.12045","volume":"78","author":"C Votsi","year":"2014","unstructured":"Votsi C, Zamba-Papanicolaou E, Middleton LT et al (2014) A novel GBA2 gene missense mutation in spastic ataxia. Ann Hum Genet 78:13\u201322. https:\/\/doi.org\/10.1111\/ahg.12045","journal-title":"Ann Hum Genet"},{"key":"749_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ajhg.2012.12.012","volume":"92","author":"MB Hammer","year":"2013","unstructured":"Hammer MB, Eleuch-Fayache G, Schottlaender LV et al (2013) Mutations in GBA2 cause autosomal-recessive cerebellar ataxia with spasticity. Am J Hum Genet 92:245\u2013251. https:\/\/doi.org\/10.1016\/j.ajhg.2012.12.012","journal-title":"Am J Hum Genet"},{"key":"749_CR20","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ajhg.2012.11.021","volume":"92","author":"E Martin","year":"2013","unstructured":"Martin E, Sch\u00fcle R, Smets K et al (2013) Loss of function of glucocerebrosidase GBA2 is responsible for motor neuron defects in hereditary spastic paraplegia. Am J Hum Genet 92:238\u2013244. https:\/\/doi.org\/10.1016\/j.ajhg.2012.11.021","journal-title":"Am J Hum Genet"},{"key":"749_CR21","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1007\/s00415-016-8256-3","volume":"263","author":"Y-J Yang","year":"2016","unstructured":"Yang Y-J, Zhou Z-F, Liao X-X et al (2016) SPG46 and SPG56 are rare causes of hereditary spastic paraplegia in China. J Neurol 263:2136\u20132138. https:\/\/doi.org\/10.1007\/s00415-016-8256-3","journal-title":"J Neurol"},{"key":"749_CR22","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1001\/archneur.65.3.393","volume":"65","author":"A Boukhris","year":"2008","unstructured":"Boukhris A, Stevanin G, Feki I et al (2008) Hereditary spastic paraplegia with mental impairment and thin corpus callosum in Tunisia: SPG11, SPG15, and further genetic heterogeneity. Arch Neurol 65:393\u2013402. https:\/\/doi.org\/10.1001\/archneur.65.3.393","journal-title":"Arch Neurol"},{"key":"749_CR23","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1515\/hsz-2018-0438","volume":"400","author":"K Harzer","year":"2019","unstructured":"Harzer K, Yildiz Y, Beck-W\u00f6dl S (2019) Assay of \u03b2-glucosidase 2 (GBA2) activity using lithocholic acid \u03b2-3-O-glucoside substrate for cultured fibroblasts and glucosylceramide for brain tissue. Biol Chem 400:745\u2013752. https:\/\/doi.org\/10.1515\/hsz-2018-0438","journal-title":"Biol Chem"},{"key":"749_CR24","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3389\/fnmol.2017.00386","volume":"10","author":"MA Woeste","year":"2017","unstructured":"Woeste MA, Wachten D (2017) The enigmatic role of GBA2 in controlling locomotor function. Front Mol Neurosci 10:386. https:\/\/doi.org\/10.3389\/fnmol.2017.00386","journal-title":"Front Mol Neurosci"},{"key":"749_CR25","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3390\/cells8040364","volume":"8","author":"GM Riboldi","year":"2019","unstructured":"Riboldi GM, Di Fonzo AB (2019) GBA, Gaucher disease, and Parkinson\u2019s disease: from genetic to clinic to new therapeutic approaches. Cells 8:364. https:\/\/doi.org\/10.3390\/cells8040364","journal-title":"Cells"},{"key":"749_CR26","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.3390\/ijms19103099","volume":"19","author":"A Malekkou","year":"2018","unstructured":"Malekkou A, Samarani M, Drousiotou A et al (2018) Biochemical characterization of the GBA2 c.1780G>C missense mutation in lymphoblastoid cells from patients with spastic ataxia. Int J Mol Sci 19:3099. https:\/\/doi.org\/10.3390\/ijms19103099","journal-title":"Int J Mol Sci"},{"key":"749_CR27","doi-asserted-by":"publisher","first-page":"e0169309","DOI":"10.1371\/journal.pone.0169309","volume":"12","author":"K Haugarvoll","year":"2017","unstructured":"Haugarvoll K, Johansson S, Rodriguez CE et al (2017) GBA2 mutations cause a Marinesco-Sj\u00f6gren-like syndrome: genetic and biochemical studies. PLoS One 12:e0169309. https:\/\/doi.org\/10.1371\/journal.pone.0169309","journal-title":"PLoS One"},{"key":"749_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.bbrc.2015.07.112","volume":"465","author":"S Sultana","year":"2015","unstructured":"Sultana S, Reichbauer J, Sch\u00fcle R et al (2015) Lack of enzyme activity in GBA2 mutants associated with hereditary spastic paraplegia\/cerebellar ataxia (SPG46). Biochem Biophys Res Commun 465:35\u201340. https:\/\/doi.org\/10.1016\/j.bbrc.2015.07.112","journal-title":"Biochem Biophys Res Commun"},{"key":"749_CR29","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1007\/s10072-021-05463-0","volume":"42","author":"M Gatti","year":"2021","unstructured":"Gatti M, Magri S, Di Bella D et al (2021) Spastic paraplegia type 46: novel and recurrent GBA2 gene variants in a compound heterozygous Italian patient with spastic ataxia phenotype. Neurol Sci 42:4741\u20134745. https:\/\/doi.org\/10.1007\/s10072-021-05463-0","journal-title":"Neurol Sci"},{"key":"749_CR30","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3389\/fneur.2018.00981","volume":"9","author":"A D\u2019Amore","year":"2018","unstructured":"D\u2019Amore A, Tessa A, Casali C et al (2018) Next generation molecular diagnosis of hereditary spastic paraplegias: an Italian cross-sectional study. Front Neurol 9:981. https:\/\/doi.org\/10.3389\/fneur.2018.00981","journal-title":"Front Neurol"},{"key":"749_CR31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189\u2013198. https:\/\/doi.org\/10.1016\/0022-3956(75)90026-6","journal-title":"J Psychiatr Res"},{"key":"749_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0009-8981(79)90396-6","volume":"92","author":"L Svennerholm","year":"1979","unstructured":"Svennerholm L, H\u00e5kansson G, M\u00e5nsson JE, Vanier MT (1979) The assay of sphingolipid hydrolases in white blood cells with labelled natural substrates. Clin Chim Acta 92:53\u201364. https:\/\/doi.org\/10.1016\/0009-8981(79)90396-6","journal-title":"Clin Chim Acta"},{"key":"749_CR33","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.clinbiochem.2017.02.013","volume":"50","author":"U Vespasiani-Gentilucci","year":"2017","unstructured":"Vespasiani-Gentilucci U, D\u2019Amico J, De Vincentis A et al (2017) Platelet count may impact on lysosomal acid lipase activity determination in dried blood spot. Clin Biochem 50:726\u2013728. https:\/\/doi.org\/10.1016\/j.clinbiochem.2017.02.013","journal-title":"Clin Biochem"},{"key":"749_CR34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"749_CR35","doi-asserted-by":"crossref","unstructured":"Gill S, Gill S, Williamson M, Avila JD (2023) A rare case of hereditary spastic paraplegia 46 with novel compound heterozygous GBA2 gene variants (P3\u20138.013). In: Sunday, April 23. Lippincott Williams & Wilkins, pp 3171","DOI":"10.1212\/WNL.0000000000203075"},{"key":"749_CR36","doi-asserted-by":"publisher","first-page":"105676","DOI":"10.1016\/j.clineuro.2020.105676","volume":"191","author":"C Spagnoli","year":"2020","unstructured":"Spagnoli C, Schiavoni S, Rizzi S et al (2020) New biallelic GBA2 variant in a patient with SPG46. Clin Neurol Neurosurg 191:105676. https:\/\/doi.org\/10.1016\/j.clineuro.2020.105676","journal-title":"Clin Neurol Neurosurg"},{"key":"749_CR37","doi-asserted-by":"publisher","first-page":"26052","DOI":"10.1074\/jbc.M113.463562","volume":"288","author":"CM Ridley","year":"2013","unstructured":"Ridley CM, Thur KE, Shanahan J et al (2013) \u03b2-Glucosidase 2 (GBA2) activity and imino sugar pharmacology. J Biol Chem 288:26052\u201326066. https:\/\/doi.org\/10.1074\/jbc.M113.463562","journal-title":"J Biol Chem"},{"key":"749_CR38","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/gim.2015.139","volume":"18","author":"D Kancheva","year":"2016","unstructured":"Kancheva D, Atkinson D, De Rijk P et al (2016) Novel mutations in genes causing hereditary spastic paraplegia and Charcot-Marie-Tooth neuropathy identified by an optimized protocol for homozygosity mapping based on whole-exome sequencing. Genet Med 18:600\u2013607. https:\/\/doi.org\/10.1038\/gim.2015.139","journal-title":"Genet Med"},{"key":"749_CR39","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1038\/ejhg.2016.42","volume":"24","author":"BP van de Warrenburg","year":"2016","unstructured":"van de Warrenburg BP, Schouten MI, de Bot ST et al (2016) Clinical exome sequencing for cerebellar ataxia and spastic paraplegia uncovers novel gene-disease associations and unanticipated rare disorders. Eur J Hum Genet 24:1460\u20131466. https:\/\/doi.org\/10.1038\/ejhg.2016.42","journal-title":"Eur J Hum Genet"},{"key":"749_CR40","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/ejhg.2017.124","volume":"25","author":"S Morais","year":"2017","unstructured":"Morais S, Raymond L, Mairey M et al (2017) Massive sequencing of 70 genes reveals a myriad of missing genes or mechanisms to be uncovered in hereditary spastic paraplegias. Eur J Hum Genet 25:1217\u20131228. https:\/\/doi.org\/10.1038\/ejhg.2017.124","journal-title":"Eur J Hum Genet"},{"key":"749_CR41","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1001\/jamaneurol.2017.5121","volume":"75","author":"M Coutelier","year":"2018","unstructured":"Coutelier M, Hammer MB, Stevanin G et al (2018) Efficacy of exome-targeted capture sequencing to detect mutations in known cerebellar ataxia genes. JAMA Neurol 75:591\u2013599. https:\/\/doi.org\/10.1001\/jamaneurol.2017.5121","journal-title":"JAMA Neurol"},{"key":"749_CR42","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.clineuro.2018.02.042","volume":"168","author":"G Coarelli","year":"2018","unstructured":"Coarelli G, Romano S, Travaglini L et al (2018) Novel homozygous GBA2 mutation in a patient with complicated spastic paraplegia. Clin Neurol Neurosurg 168:60\u201363. https:\/\/doi.org\/10.1016\/j.clineuro.2018.02.042","journal-title":"Clin Neurol Neurosurg"},{"key":"749_CR43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-019-0157-9","volume":"8","author":"Q Wei","year":"2019","unstructured":"Wei Q, Dong H-L, Pan L-Y et al (2019) Clinical features and genetic spectrum in Chinese patients with recessive hereditary spastic paraplegia. Transl Neurodegener 8:19. https:\/\/doi.org\/10.1186\/s40035-019-0157-9","journal-title":"Transl Neurodegener"},{"key":"749_CR44","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.gendis.2019.07.009","volume":"8","author":"H Algahtani","year":"2021","unstructured":"Algahtani H, Shirah B, Ullah I et al (2021) Autosomal recessive cerebellar ataxia with spasticity due to a rare mutation in GBA2 gene in a large consanguineous Saudi family. Genes Dis 8:110\u2013114. https:\/\/doi.org\/10.1016\/j.gendis.2019.07.009","journal-title":"Genes Dis"},{"key":"749_CR45","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/cge.13669","volume":"97","author":"R-Y Guan","year":"2020","unstructured":"Guan R-Y, Wu J-J, Ding Z-T et al (2020) Clinical and genetic findings in a cohort of Chinese patients with autosomal recessive spinocerebellar ataxia. Clin Genet 97:532\u2013535. https:\/\/doi.org\/10.1111\/cge.13669","journal-title":"Clin Genet"},{"key":"749_CR46","doi-asserted-by":"publisher","first-page":"100238","DOI":"10.1016\/j.ensci.2020.100238","volume":"19","author":"K Nakamura-Shindo","year":"2020","unstructured":"Nakamura-Shindo K, Ono K, Koh K et al (2020) A novel mutation in the GBA2 gene in a Japanese patient with SPG46: a case report. eNeurologicalSci 19:100238. https:\/\/doi.org\/10.1016\/j.ensci.2020.100238","journal-title":"eNeurologicalSci"},{"key":"749_CR47","doi-asserted-by":"publisher","first-page":"103992","DOI":"10.1016\/j.ejmg.2020.103992","volume":"63","author":"K Kloth","year":"2020","unstructured":"Kloth K, Cozma C, Bester M et al (2020) Dystonia as initial presentation of compound heterozygous GBA2 mutations: expanding the phenotypic spectrum of SPG46. Eur J Med Genet 63:103992. https:\/\/doi.org\/10.1016\/j.ejmg.2020.103992","journal-title":"Eur J Med Genet"},{"key":"749_CR48","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.parkreldis.2020.11.007","volume":"82","author":"VV Holla","year":"2021","unstructured":"Holla VV, Surisetti BK, Prasad S et al (2021) SPG46 due to truncating mutations in GBA2: two cases from India. Parkinsonism Relat Disord 82:13\u201315. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.11.007","journal-title":"Parkinsonism Relat Disord"},{"key":"749_CR49","doi-asserted-by":"publisher","first-page":"1005670","DOI":"10.3389\/fneur.2022.1005670","volume":"13","author":"M-Y Lan","year":"2022","unstructured":"Lan M-Y, Lu C-S, Wu S-L et al (2022) Clinical and genetic characterization of a Taiwanese cohort with spastic paraparesis combined with cerebellar involvement. Front Neurol 13:1005670. https:\/\/doi.org\/10.3389\/fneur.2022.1005670","journal-title":"Front Neurol"},{"key":"749_CR50","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.nrleng.2022.06.009","volume":"38","author":"C Cores Bartolom\u00e9","year":"2023","unstructured":"Cores Bartolom\u00e9 C, Rubio Naz\u00e1bal E, Sobrido MJ, P\u00e9rez Sousa C (2023) SPG46 spastic paraplegia due to GBA2 mutation: description of the first case in Spain. Neurologia (Engl Ed) 38:372\u2013374. https:\/\/doi.org\/10.1016\/j.nrleng.2022.06.009","journal-title":"Neurologia (Engl Ed)"},{"key":"749_CR51","doi-asserted-by":"publisher","first-page":"287432","DOI":"10.1155\/2012\/287432","volume":"2012","author":"M Scarpelli","year":"2012","unstructured":"Scarpelli M, Zappini F, Filosto M et al (2012) Mitochondrial sensorineural hearing loss: a retrospective study and a description of cochlear implantation in a MELAS patient. Genet Res Int 2012:287432. https:\/\/doi.org\/10.1155\/2012\/287432","journal-title":"Genet Res Int"},{"key":"749_CR52","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3390\/medicina59030608","volume":"59","author":"V Fancello","year":"2023","unstructured":"Fancello V, Fancello G, Palma S et al (2023) The role of primary mitochondrial disorders in hearing impairment: an overview. Medicina (Kaunas) 59:608. https:\/\/doi.org\/10.3390\/medicina59030608","journal-title":"Medicina (Kaunas)"},{"key":"749_CR53","doi-asserted-by":"publisher","first-page":"e0233856","DOI":"10.1371\/journal.pone.0233856","volume":"15","author":"S Sultana","year":"2020","unstructured":"Sultana S, Stewart J, van der Spoel AC (2020) Truncated mutants of beta-glucosidase 2 (GBA2) are localized in the mitochondrial matrix and cause mitochondrial fragmentation. PLoS One 15:e0233856. https:\/\/doi.org\/10.1371\/journal.pone.0233856","journal-title":"PLoS One"},{"key":"749_CR54","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/diseases5010010","volume":"5","author":"T Roshan Lal","year":"2017","unstructured":"Roshan Lal T, Sidransky E (2017) The spectrum of neurological manifestations associated with Gaucher disease. Diseases 5:10. https:\/\/doi.org\/10.3390\/diseases5010010","journal-title":"Diseases"},{"key":"749_CR55","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3389\/fneur.2017.00711","volume":"8","author":"T Bremova-Ertl","year":"2017","unstructured":"Bremova-Ertl T, Schiffmann R, Patterson MC et al (2017) Oculomotor and vestibular findings in Gaucher disease type 3 and their correlation with neurological findings. Front Neurol 8:711. https:\/\/doi.org\/10.3389\/fneur.2017.00711","journal-title":"Front Neurol"},{"key":"749_CR56","doi-asserted-by":"publisher","unstructured":"Vitner EB, Futerman AH (2013) Neuronal forms of Gaucher disease. Handb Exp Pharmacol 405\u2013419. https:\/\/doi.org\/10.1007\/978-3-7091-1511-4_20","DOI":"10.1007\/978-3-7091-1511-4_20"},{"key":"749_CR57","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3390\/jcm9030736","volume":"9","author":"DEC Boer","year":"2020","unstructured":"Boer DEC, van Smeden J, Bouwstra JA, Aerts JMFG (2020) Glucocerebrosidase: functions in and beyond the lysosome. J Clin Med 9:736. https:\/\/doi.org\/10.3390\/jcm9030736","journal-title":"J Clin Med"},{"key":"749_CR58","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1074\/jbc.M112.414714","volume":"288","author":"HG K\u00f6rschen","year":"2013","unstructured":"K\u00f6rschen HG, Yildiz Y, Raju DN et al (2013) The non-lysosomal \u03b2-glucosidase GBA2 is a non-integral membrane-associated protein at the endoplasmic reticulum (ER) and Golgi. J Biol Chem 288:3381\u20133393. https:\/\/doi.org\/10.1074\/jbc.M112.414714","journal-title":"J Biol Chem"},{"key":"749_CR59","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/hmg\/ddp212","volume":"18","author":"A Sabbagh","year":"2009","unstructured":"Sabbagh A, Pasmant E, Laurendeau I et al (2009) Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1. Hum Mol Genet 18:2768\u20132778. https:\/\/doi.org\/10.1093\/hmg\/ddp212","journal-title":"Hum Mol Genet"},{"key":"749_CR60","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1002\/ajmg.a.34022","volume":"155A","author":"R Jobling","year":"2011","unstructured":"Jobling R, Ferrier RA, McLeod R et al (2011) Monozygotic twins with variable expression of Van der Woude syndrome. Am J Med Genet A 155A:2008\u20132010. https:\/\/doi.org\/10.1002\/ajmg.a.34022","journal-title":"Am J Med Genet A"},{"key":"749_CR61","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1136\/jmg.30.1.36","volume":"30","author":"AL Collins","year":"1993","unstructured":"Collins AL, Lunt PW, Garrett C, Dennis NR (1993) Holoprosencephaly: a family showing dominant inheritance and variable expression. J Med Genet 30:36\u201340. https:\/\/doi.org\/10.1136\/jmg.30.1.36","journal-title":"J Med Genet"},{"key":"749_CR62","doi-asserted-by":"publisher","first-page":"920390","DOI":"10.3389\/fgene.2022.920390","volume":"13","author":"R Kingdom","year":"2022","unstructured":"Kingdom R, Wright CF (2022) Incomplete penetrance and variable expressivity: from clinical studies to population cohorts. Front Genet 13:920390. https:\/\/doi.org\/10.3389\/fgene.2022.920390","journal-title":"Front Genet"},{"key":"749_CR63","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41586-019-1411-0","volume":"571","author":"G Cavalli","year":"2019","unstructured":"Cavalli G, Heard E (2019) Advances in epigenetics link genetics to the environment and disease. Nature 571:489\u2013499. https:\/\/doi.org\/10.1038\/s41586-019-1411-0","journal-title":"Nature"},{"key":"749_CR64","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1399-0004.1977.tb01279.x","volume":"11","author":"H Skre","year":"1977","unstructured":"Skre H, Berg K (1977) Linkage studies on Marinesco-Sj\u00f8gren syndrome and hypergonadotropic hypogonadism. Clin Genet 11:57\u201366. https:\/\/doi.org\/10.1111\/j.1399-0004.1977.tb01279.x","journal-title":"Clin Genet"},{"key":"749_CR65","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1038\/ng1677","volume":"37","author":"A-K Anttonen","year":"2005","unstructured":"Anttonen A-K, Mahjneh I, H\u00e4m\u00e4l\u00e4inen RH et al (2005) The gene disrupted in Marinesco-Sj\u00f6gren syndrome encodes SIL1, an HSPA5 cochaperone. Nat Genet 37:1309\u20131311. https:\/\/doi.org\/10.1038\/ng1677","journal-title":"Nat Genet"},{"key":"749_CR66","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1038\/ng1678","volume":"37","author":"J Senderek","year":"2005","unstructured":"Senderek J, Krieger M, Stendel C et al (2005) Mutations in SIL1 cause Marinesco-Sj\u00f6gren syndrome, a cerebellar ataxia with cataract and myopathy. Nat Genet 37:1312\u20131314. https:\/\/doi.org\/10.1038\/ng1678","journal-title":"Nat Genet"},{"key":"749_CR67","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.1093\/brain\/awt283","volume":"136","author":"M Krieger","year":"2013","unstructured":"Krieger M, Roos A, Stendel C et al (2013) SIL1 mutations and clinical spectrum in patients with Marinesco-Sjogren syndrome. Brain 136:3634\u20133644. https:\/\/doi.org\/10.1093\/brain\/awt283","journal-title":"Brain"},{"key":"749_CR68","unstructured":"Anttonen AK. Marinesco-Sj\u00f6gren Syndrome. 2006 Nov 29 [Updated 2019 Jan 10]. In: Adam MP, Feldman J, Mirzaa GM, et al (eds) GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1192\/"},{"key":"749_CR69","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1007\/s11064-012-0719-z","volume":"37","author":"M Aureli","year":"2012","unstructured":"Aureli M, Gritti A, Bassi R et al (2012) Plasma membrane-associated glycohydrolases along differentiation of murine neural stem cells. Neurochem Res 37:1344\u20131354. https:\/\/doi.org\/10.1007\/s11064-012-0719-z","journal-title":"Neurochem Res"},{"key":"749_CR70","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1074\/jbc.M610544200","volume":"282","author":"RG Boot","year":"2007","unstructured":"Boot RG, Verhoek M, Donker-Koopman W et al (2007) Identification of the non-lysosomal glucosylceramidase as beta-glucosidase 2. J Biol Chem 282:1305\u20131312. https:\/\/doi.org\/10.1074\/jbc.M610544200","journal-title":"J Biol Chem"},{"key":"749_CR71","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1074\/jbc.RA118.006311","volume":"294","author":"MA Woeste","year":"2019","unstructured":"Woeste MA, Stern S, Raju DN et al (2019) Species-specific differences in nonlysosomal glucosylceramidase GBA2 function underlie locomotor dysfunction arising from loss-of-function mutations. J Biol Chem 294:3853\u20133871. https:\/\/doi.org\/10.1074\/jbc.RA118.006311","journal-title":"J Biol Chem"},{"key":"749_CR72","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/humrep\/del414","volume":"22","author":"JK Amory","year":"2007","unstructured":"Amory JK, Muller CH, Page ST et al (2007) Miglustat has no apparent effect on spermatogenesis in normal men. Hum Reprod 22:702\u2013707. https:\/\/doi.org\/10.1093\/humrep\/del414","journal-title":"Hum Reprod"},{"key":"749_CR73","doi-asserted-by":"publisher","first-page":"717","DOI":"10.2217\/14622416.9.6.717","volume":"9","author":"AC van der Spoel","year":"2008","unstructured":"van der Spoel AC, Mott R, Platt FM (2008) Differential sensitivity of mouse strains to an N-alkylated imino sugar: glycosphingolipid metabolism and acrosome formation. Pharmacogenomics 9:717\u2013731. https:\/\/doi.org\/10.2217\/14622416.9.6.717","journal-title":"Pharmacogenomics"},{"key":"749_CR74","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/mt.2016.53","volume":"24","author":"J Marshall","year":"2016","unstructured":"Marshall J, Sun Y, Bangari DS et al (2016) CNS-accessible inhibitor of glucosylceramide synthase for substrate reduction therapy of neuronopathic Gaucher disease. Mol Ther 24:1019\u20131029. https:\/\/doi.org\/10.1038\/mt.2016.53","journal-title":"Mol Ther"},{"key":"749_CR75","doi-asserted-by":"publisher","unstructured":"Sardi SP, Viel C, Clarke J, et al (2017) Glucosylceramide synthase inhibition alleviates aberrations in synucleinopathy models. Proc Natl Acad Sci U S A 114:2699\u20132704.https:\/\/doi.org\/10.1073\/pnas.1616152114","DOI":"10.1073\/pnas.1616152114"}],"container-title":["Neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-024-00749-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10048-024-00749-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-024-00749-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T10:12:10Z","timestamp":1715076730000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10048-024-00749-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,9]]},"references-count":75,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["749"],"URL":"https:\/\/doi.org\/10.1007\/s10048-024-00749-9","relation":{},"ISSN":["1364-6753"],"issn-type":[{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,9]]},"assertion":[{"value":"25 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This multicentric case series study was performed in accordance with the Declaration of Helsinki statements. Written informed consent and ethical approval (CE Lazio) were obtained. We thank the contribution of Ricerca Corrente 2023 of the Italian Ministry of Health. The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}}]}}